Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Follow-up data presented for Bexxar cancer therapy

June 15, 1999

Theragyn improves long-term survival in ovarian cancer patients

June 14, 1999

Data from phase I/II study of NBI-3001 presented at German Society of Neurosurgery

June 11, 1999

Dendreon moves ahead with dendritic cell therapies for cancer

June 10, 1999

Maxamine plus IL-2 prolongs duration of complete remission in patients with AML

June 10, 1999

European Commission issues first approval for tasonermin

June 8, 1999

LifeTime and Dovetail enter exclusive agreement for Beta LT anticancer compound

June 8, 1999

AVI BioPharma to initiate phase II clinical trial of Avicine in pancreatic cancer

June 7, 1999

Additional phase II data suggest modifications for AVI BioPharma's cancer vaccine

June 1, 1999

Phase II trial of York Medical's cancer vaccine cleared

June 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...